Prevalence of Colon Cancer in Pyogenic Liver Abscess

February 26, 2016 updated by: Tae Oh Kim, Inje University

The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Busan, Korea, Republic of
        • Inje University Haeundae Paik Hospital
    • Gyeongsangnam-do
      • Yangsan-si, Gyeongsangnam-do, Korea, Republic of
        • Pusan National Unversity Yangsan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The patients diagnosed as pyogenic liver abscess, the cause of which is not found at initial evaluation

Description

Inclusion Criteria:

  • Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion Criteria:

  • Amebic liver abscess
  • Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
  • Refusal to colonoscopic examination
  • Inadequate general patient status to perform the colonoscopic examination
  • Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Colonoscopic examination group
The patients diagnosed with cryptogenic pyogenic liver abscess

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The prevalence of colonic neoplasm
Time Frame: within 6 weeks after diagnosis of pyogenic liver abscess
within 6 weeks after diagnosis of pyogenic liver abscess

Secondary Outcome Measures

Outcome Measure
Time Frame
Prevalence of colon polyp
Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess
Within 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of colonic diverticulitis
Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess
Within 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of inflammatory bowel disease
Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess
Within 6 weeks at diagnosis of pyogenic liver abscess
Prevalence of intestinal tuberculosis
Time Frame: Within 6 weeks at diagnosis of pyogenic liver abscess
Within 6 weeks at diagnosis of pyogenic liver abscess

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Inje University

Collaborators

Pusan National University Yangsan Hospital

Investigators

  • Principal Investigator: Tae Oh Kim, M.D., Inje University Haeundae Paik Hosptial

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

January 8, 2014

First Submitted That Met QC Criteria

January 8, 2014

First Posted (Estimate)

January 10, 2014

Study Record Updates

Last Update Posted (Estimate)

March 1, 2016

Last Update Submitted That Met QC Criteria

February 26, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cryptogenic Pyogenic Liver Abscess

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe